The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target

Abstract Keloids are benign fibroproliferative skin tumors caused by aberrant wound healing that can negatively impact patient quality of life. The lack of animal models has limited research on pathogenesis or developing effective treatments, and the etiology of keloids remains unknown. Here, we fou...

Full description

Bibliographic Details
Main Authors: Mamiko Tosa, Yoshinori Abe, Seiko Egawa, Tomoka Hatakeyama, Chihiro Iwaguro, Ryotaro Mitsugi, Ayaka Moriyama, Takumi Sano, Rei Ogawa, Nobuyuki Tanaka
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-023-05561-z
_version_ 1797397828654333952
author Mamiko Tosa
Yoshinori Abe
Seiko Egawa
Tomoka Hatakeyama
Chihiro Iwaguro
Ryotaro Mitsugi
Ayaka Moriyama
Takumi Sano
Rei Ogawa
Nobuyuki Tanaka
author_facet Mamiko Tosa
Yoshinori Abe
Seiko Egawa
Tomoka Hatakeyama
Chihiro Iwaguro
Ryotaro Mitsugi
Ayaka Moriyama
Takumi Sano
Rei Ogawa
Nobuyuki Tanaka
author_sort Mamiko Tosa
collection DOAJ
description Abstract Keloids are benign fibroproliferative skin tumors caused by aberrant wound healing that can negatively impact patient quality of life. The lack of animal models has limited research on pathogenesis or developing effective treatments, and the etiology of keloids remains unknown. Here, we found that the characteristics of stem-like cells from keloid lesions and the surrounding dermis differ from those of normal skin. Furthermore, the HEDGEHOG (HH) signal and its downstream transcription factor GLI1 were upregulated in keloid patient–derived stem-like cells. Inhibition of the HH-GLI1 pathway reduced the expression of genes involved in keloids and fibrosis-inducing cytokines, including osteopontin. Moreover, the HH signal inhibitor vismodegib reduced keloid reconstituted tumor size and keloid-related gene expression in nude mice and the collagen bundle and expression of cytokines characteristic for keloids in ex vivo culture of keloid tissues. These results implicate the HH-GLI1 pathway in keloid pathogenesis and suggest therapeutic targets of keloids.
first_indexed 2024-03-09T01:15:51Z
format Article
id doaj.art-a92b1da720804ee68c4542d1984c0cd3
institution Directory Open Access Journal
issn 2399-3642
language English
last_indexed 2024-03-09T01:15:51Z
publishDate 2023-12-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj.art-a92b1da720804ee68c4542d1984c0cd32023-12-10T12:28:34ZengNature PortfolioCommunications Biology2399-36422023-12-016111610.1038/s42003-023-05561-zThe HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic targetMamiko Tosa0Yoshinori Abe1Seiko Egawa2Tomoka Hatakeyama3Chihiro Iwaguro4Ryotaro Mitsugi5Ayaka Moriyama6Takumi Sano7Rei Ogawa8Nobuyuki Tanaka9Department of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolDepartment of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical SchoolDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical SchoolAbstract Keloids are benign fibroproliferative skin tumors caused by aberrant wound healing that can negatively impact patient quality of life. The lack of animal models has limited research on pathogenesis or developing effective treatments, and the etiology of keloids remains unknown. Here, we found that the characteristics of stem-like cells from keloid lesions and the surrounding dermis differ from those of normal skin. Furthermore, the HEDGEHOG (HH) signal and its downstream transcription factor GLI1 were upregulated in keloid patient–derived stem-like cells. Inhibition of the HH-GLI1 pathway reduced the expression of genes involved in keloids and fibrosis-inducing cytokines, including osteopontin. Moreover, the HH signal inhibitor vismodegib reduced keloid reconstituted tumor size and keloid-related gene expression in nude mice and the collagen bundle and expression of cytokines characteristic for keloids in ex vivo culture of keloid tissues. These results implicate the HH-GLI1 pathway in keloid pathogenesis and suggest therapeutic targets of keloids.https://doi.org/10.1038/s42003-023-05561-z
spellingShingle Mamiko Tosa
Yoshinori Abe
Seiko Egawa
Tomoka Hatakeyama
Chihiro Iwaguro
Ryotaro Mitsugi
Ayaka Moriyama
Takumi Sano
Rei Ogawa
Nobuyuki Tanaka
The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
Communications Biology
title The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
title_full The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
title_fullStr The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
title_full_unstemmed The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
title_short The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
title_sort hedgehog gli1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
url https://doi.org/10.1038/s42003-023-05561-z
work_keys_str_mv AT mamikotosa thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT yoshinoriabe thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT seikoegawa thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT tomokahatakeyama thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT chihiroiwaguro thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT ryotaromitsugi thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT ayakamoriyama thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT takumisano thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT reiogawa thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT nobuyukitanaka thehedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT mamikotosa hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT yoshinoriabe hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT seikoegawa hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT tomokahatakeyama hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT chihiroiwaguro hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT ryotaromitsugi hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT ayakamoriyama hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT takumisano hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT reiogawa hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget
AT nobuyukitanaka hedgehoggli1pathwayisimportantforfibroproliferativepropertiesinkeloidsandasacandidatetherapeutictarget